Management of platelet-directed pharmacotherapy in patients with atherosclerotic coronary artery disease undergoing elective endoscopic gastrointestinal procedures Review uri icon

Overview

MeSH Major

  • Coronary Artery Disease
  • Endoscopy, Gastrointestinal
  • Platelet Aggregation Inhibitors
  • Thrombolytic Therapy

abstract

  • The periprocedural management of patients with atherosclerotic coronary heart disease, including those who have heart disease and those who are undergoing percutaneous coronary intervention and stent placement who might require temporary interruption of platelet-directed pharmacotherapy for the purpose of an elective endoscopic gastrointestinal procedure, is a common clinical scenario in daily practice. Herein, we summarize the available information that can be employed for making management decisions and provide general guidance for risk assessment.

publication date

  • December 2009

Research

keywords

  • Review

Identity

Language

  • eng

Digital Object Identifier (DOI)

  • 10.1038/ajg.2009.667

PubMed ID

  • 19935784

Additional Document Info

start page

  • 2903

end page

  • 17

volume

  • 104

number

  • 12